Also researched here: Physics and Astronomy, Biochemistry, Genetics and Molecular Biology, Earth and Planetary Sciences, Neuroscience, Engineering, Materials Science, Medicine, Business, Management and Accounting, Agricultural and Biological Sciences, Social Sciences, Psychology, Environmental Science, Immunology and Microbiology, Computer Science, Health Professions, Mathematics, Chemistry.
No professors listed yet
Professors are added as their public research records are checked. Meanwhile, the university's own department pages list its academic staff.
Open PhD, Masters & Postdoc positions
Marie Curie AI for Proteomics PhD Position (Lilley Group) - (Fixed Term)
- Cambridge, United Kingdom
- Department of Biochemistry
- Professor Kathryn Lilley
Location: Central Cambridge We are seeking applications for a PhD position in AI in proteomics as part of the Horizon Europe MSCA Doctoral Network, ProtAIomics. This brings together laboratories across Europe with 16 doctoral students at the interface of artificial intelligence and mass spectrometry proteomics. In collaboration with researchers at the University of Oxford, we seek a candidate to develop AI tools for the interrogation of subcellular proteomics data. We are interested to hear from candidates with experience in probabilistic or statistical modelling of complex biological data, su
PhD Studentship: Developing Fair and Robust Cancer Risk Prediction Models Using Health Data
- Cambridge, United Kingdom
- Department of Public Health and Primary Care - Cardiovascular Epidemiology Unit
- Professor Angela Wood
Fully Funded PhD Studentship (Home Fees) Project Title: Developing Fair and Robust Cancer Risk Prediction Models Using Health Data Supervisor: Professor Angela Wood (Professor of Biostatistics and Health Data Science) Start date: January 2027 (or earlier) We are offering an exciting fully funded PhD studentship at the University of Cambridge, embedded within Cancer Data Driven Detection (CD3) - a major £10 million national research programme bringing together leading experts in cancer epidemiology, biostatistics, artificial intelligence, and health data science. THE PROJECT: Early cancer diagn
PhD Studentship: Unmasking mechanisms of resistance to KRAS inhibition across pancreatic cancer genetic profiles
- Cambridge, United Kingdom
- Cancer Research UK Cambridge Institute
- Dr Giulia Biffi
Supervisor: Dr Giulia Biffi Course start date: 1st October 2027 Project details For further information about the research group, including their most recent publications, please visit their website at https://biffilab.wordpress.com Pancreatic ductal adenocarcinoma (PDAC) remains a formidable clinical challenge. A major recent advance has been the development of KRAS inhibitors, which have shown considerable promise in clinical trials (1). For decades, KRAS was considered undruggable; however, these new inhibitors represent a potential turning point for patients with PDAC. Despite this progres
PhD Studentship: Discovery of rational therapeutic biomarkers in breast cancer by systems pathology and deep learning
- Cambridge, United Kingdom
- Cancer Research UK Cambridge Institute
- Dr Hamid Raza Ali
PhD studentship: Discovery of rational therapeutic biomarkers in breast cancer by systems pathology and deep learning Supervisor: Dr Hamid Raza Ali Department/location: Cancer Research UK Cambridge Institute Deadline for application: 16th October 2026 Course start date: 1st October 2027 Overview The Ali Lab wishes to recruit a student to work on the project entitled: "Discovery of rational therapeutic biomarkers in breast cancer by systems pathology and deep learning". For further information about the research group, including their most recent publications, please visit their website at www.
Fully-funded PhD Studentship: Understanding the identity and function of tumour-initiating states
- Cambridge, United Kingdom
- Cancer Research UK Cambridge Institute
- Prof Masashi Narita
Supervisor: Prof Masashi Narita Course start date: 1st October 2027 Project details For further information about the research group, including their most recent publications, please visit their website at https://www.naritalab.com/ Our laboratory investigates the biology of preneoplastic cell states, with particular interest in how changes in cell functional identity and plasticity are controlled by the epigenome. We are interested in how oncogenic and metabolic signalling reshapes chromatin organisation and gene regulation, how these changes influence cellular fitness and tissue microenviron
Fully-funded PhD Studentship: Single-cell spatial multi-omics for cancer biology
- Cambridge, United Kingdom
- Cancer Research UK Cambridge Institute
- Dr Guiping Wang
Supervisor: Dr Guiping Wang Course start date: 1st October 2027 Project details For further information about the research group, please visit our website at https://www.cruk.cam.ac.uk/research-groups/wang-group/ In the Wang Group, we develop and apply interdisciplinary technologies that bridge high-resolution spatial biology and genome-wide discovery. By integrating multi-omic sequencing and quantitative imaging, we work towards a multi-scale understanding of how molecular composition and subcellular organisation shape cell function, plasticity and disease. A central biology focus of the lab
Fully-funded PhD Studentship: Innate-adaptive immune interactions in cancer evolution
- Cambridge, United Kingdom
- Cancer Research UK Cambridge Institute
- Dr Tim Halim
Supervisor: Dr Tim Halim Course start date: 1st October 2027 Project details For further information about the research group, please visit our website at https://www.cruk.cam.ac.uk/research-groups/halim-group/ The immune system is capable of detecting cancer, which forms the basis of immunotherapy. While immunotherapy has revolutionised cancer treatment in recent years, it remains unclear how exactly the immue system detects and responds to pre-cancereous lesions. Nevertheless, it is known that the activatin (or deactivation) of anti-cancer immune cells involves many different cell-types that
AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based Radioconjugates
- Cambridge, United Kingdom
- Department of Radiology
- Professor Luigi Aloj
Applications are invited for an AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based Radioconjugates Using In Vivo PET Imaging and Multimodal Ex Vivo Tissue Analysis. The Department of Radiology at the University of Cambridge, in partnership with AstraZeneca, is offering a funded PhD studentship to develop innovative approaches for the safety assessment of next-generation radiopharmaceuticals. We are seeking a motivated, enthusiastic and inquisitive student with an interest in molecular imaging,